{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:07:42Z","timestamp":1788559662937,"version":"build-2803163510"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>\n                      The acquired form of 5-oxoproline (pyroglutamic acid) metabolic acidosis was first described in 1989 and its relationship to chronic acetaminophen ingestion was proposed the next year. Since then, this cause of chronic anion gap metabolic acidosis has been increasingly recognized. Many cases go unrecognized because an assay for 5-oxoproline is not widely available. Most cases occur in malnourished, chronically ill women with a history of chronic acetaminophen ingestion. Acetaminophen levels are very rarely in the toxic range; rather, they are usually therapeutic or low. The disorder generally resolves with cessation of acetaminophen and administration of intravenous fluids. Methionine or\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetyl cysteine may accelerate resolution and methionine is protective in a rodent model. The disorder has been attributed to glutathione depletion and activation of a key enzyme in the\n                      <jats:italic toggle=\"yes\">\u03b3<\/jats:italic>\n                      -glutamyl cycle. However, the specific metabolic derangements that cause the 5-oxoproline accumulation remain unclear. An ATP-depleting futile 5-oxoproline cycle can explain the accumulation of 5-oxoproline after chronic acetaminophen ingestion. This cycle is activated by the depletion of both glutathione and cysteine. This explanation contributes to our understanding of acetaminophen-induced 5-oxoproline metabolic acidosis and the beneficial role of\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetyl cysteine therapy. The ATP-depleting futile 5-oxoproline cycle may also play a role in the energy depletions that occur in other acetaminophen-related toxic syndromes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.07730713","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:47:03Z","timestamp":1384476423000},"page":"191-200","source":"Crossref","is-referenced-by-count":101,"title":["Acetaminophen Toxicity and 5-Oxoproline (Pyroglutamic Acid)"],"prefix":"10.2215","volume":"9","author":[{"given":"Michael","family":"Emmett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20230811","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/20014091111677","article-title":"Paracetamol (acetaminophen)-induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches.","volume":"31","author":"Bessems","year":"2001","journal-title":"Crit Rev Toxicol"},{"key":"R2-26-20230811","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis.","volume":"196","author":"Hinson","year":"2010","journal-title":"Handbook Exp Pharmacol"},{"key":"R3-26-20230811","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.","volume":"122","author":"McGill","year":"2012","journal-title":"J Clin Invest"},{"key":"R4-26-20230811","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0960327109350799","article-title":"Delayed onset of acute renal failure after significant paracetamol overdose: A case series.","volume":"29","author":"Waring","year":"2010","journal-title":"Hum Exp Toxicol"},{"key":"R5-26-20230811","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF03160941","article-title":"Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management.","volume":"4","author":"Mazer","year":"2008","journal-title":"J Med Toxicol"},{"key":"R6-26-20230811","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2125.2007.02952.x","article-title":"Effect of acute paracetamol overdose on changes in serum and urine electrolytes.","volume":"64","author":"Pakravan","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"R7-26-20230811","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(89)90724-1","article-title":"Hypophosphataemia and phosphaturia in paracetamol poisoning.","volume":"2","author":"Jones","year":"1989","journal-title":"Lancet"},{"key":"R8-26-20230811","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clinchem\/35.4.684","article-title":"Pyroglutamic acidemia in an adult patient.","volume":"35","author":"Creer","year":"1989","journal-title":"Clin Chem"},{"key":"R9-26-20230811","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF01799581","article-title":"Atypical pyroglutamic aciduria: Possible role of paracetamol.","volume":"13","author":"Pitt","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"R10-26-20230811","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/44.7.1497","article-title":"Transient 5-oxoprolinuria and high anion gap metabolic acidosis: Clinical and biochemical findings in eleven subjects.","volume":"44","author":"Pitt","year":"1998","journal-title":"Clin Chem"},{"key":"R11-26-20230811","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004310051054","article-title":"5-Oxoprolinuria in patients with and without defects in the \u03b3-glutamyl cycle.","volume":"158","author":"Mayatepek","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R12-26-20230811","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00003246-200006000-00018","article-title":"Pyroglutamic acidemia: A cause of high anion gap metabolic acidosis.","volume":"28","author":"Dempsey","year":"2000","journal-title":"Crit Care Med"},{"key":"R13-26-20230811","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1053\/j.ajkd.2005.03.021","article-title":"Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid).","volume":"46","author":"Tailor","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R14-26-20230811","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2005.04.010","article-title":"Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.","volume":"46","author":"Humphreys","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R15-26-20230811","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1093\/ndt\/gfi184","article-title":"Pyroglutamic acidosis in a renal transplant patient.","volume":"20","author":"Foot","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R16-26-20230811","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5694\/j.1326-5377.2006.tb00537.x","article-title":"An unusual cause of severe metabolic acidosis.","volume":"185","author":"Peter","year":"2006","journal-title":"Med J Aust"},{"key":"R17-26-20230811","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2215\/CJN.01411005","article-title":"Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): A role for acetaminophen.","volume":"1","author":"Fenves","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-26-20230811","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1695-4033(07)70808-1","article-title":"Acidosis piroglut\u00e1mica asociada a paracetamol.","volume":"67","author":"Alados Arboledas","year":"2007","journal-title":"An Pediatr (Barc"},{"key":"R19-26-20230811","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF03160921","article-title":"Profound metabolic acidosis and oxoprolinuria in an adult.","volume":"3","author":"Hodgman","year":"2007","journal-title":"J Med Toxicol"},{"key":"R20-26-20230811","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1258\/000456307780945769","article-title":"High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): Association with prescription drugs and malnutrition.","volume":"44","author":"Brooker","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"R21-26-20230811","first-page":"351","article-title":"Guilty as charged: Unmeasured urinary anions in a case of pyroglutamic acidosis.","volume":"66","author":"Rolleman","year":"2008","journal-title":"Neth J Med"},{"key":"R22-26-20230811","first-page":"354","article-title":"5-Oxoproline as a cause of high anion gap metabolic acidosis: An uncommon cause with common risk factors.","volume":"66","author":"Kortmann","year":"2008","journal-title":"Neth J Med"},{"key":"R23-26-20230811","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S148180350001263X","article-title":"Profound metabolic acidosis from pyroglutamic acidemia: An underappreciated cause of high anion gap metabolic acidosis.","volume":"12","author":"Green","year":"2010","journal-title":"CJEM"},{"key":"R24-26-20230811","first-page":"545","article-title":"5-oxoproline-induced anion gap metabolic acidosis after an acute acetaminophen overdose.","volume":"110","author":"Lawrence","year":"2010","journal-title":"J Am Osteopath Assoc"},{"key":"R25-26-20230811","first-page":"19","article-title":"5-Oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use.","volume":"23","author":"Duewall","year":"2010","journal-title":"Proc (Bayl Univ Med Cent"},{"key":"R26-26-20230811","first-page":"254","article-title":"Case report: Pyroglutamic acidaemia as a likely cause of high anion gap metabolic acidosis.","volume":"16","author":"Wong","year":"2011","journal-title":"Respirology"},{"key":"R28-26-20230811","first-page":"312","article-title":"Pyroglutamic aciduria: A cause of high anion-gap metabolic acidosis associated with common drugs.","volume":"104","author":"Chestnutt","year":"2011","journal-title":"Ir Med J"},{"key":"R30-26-20230811","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2125.2011.04120.x","article-title":"5-Oxoprolinuria as a cause of high anion gap metabolic acidosis.","volume":"73","author":"Verma","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"R31-26-20230811","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(10)61383-9","article-title":"Mind the gap! An unusual metabolic acidosis.","volume":"377","author":"Myall","year":"2011","journal-title":"Lancet"},{"key":"R33-26-20230811","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/EJA.0b013e328354243f","article-title":"Madam, why are you so sour? Cause, diagnosis and complication of 5-oxoprolinemia.","volume":"29","author":"Veldhuijzen","year":"2012","journal-title":"Eur J Anaesthesiol"},{"key":"R34-26-20230811","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MAJ.0b013e318259bd45","article-title":"Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation.","volume":"344","author":"Zand","year":"2012","journal-title":"Am J Med Sci"},{"key":"R35-26-20230811","first-page":"U317","article-title":"A case of high anion gap metabolic acidosis: What\u2019s the anion?","volume":"40","author":"Prasad","year":"2012","journal-title":"Crit Care Med"},{"key":"R36-26-20230811","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jemermed.2011.06.017","article-title":"5-oxoprolinemia causing elevated anion gap metabolic acidosis in the setting of acetaminophen use.","volume":"43","author":"Armenian","year":"2012","journal-title":"J Emerg Med"},{"key":"R37-26-20230811","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/imj.12016","article-title":"A rare cause of high anion gap metabolic acidosis.","volume":"43","author":"Milosevic","year":"2013","journal-title":"Intern Med J"},{"key":"R38-26-20230811","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12038-010-0004-8","article-title":"A futile cycle, formed between two ATP-dependant \u03b3-glutamyl cycle enzymes, \u03b3-glutamyl cysteine synthetase and 5-oxoprolinase: The cause of cellular ATP depletion in nephrotic cystinosis?","volume":"35","author":"Kumar","year":"2010","journal-title":"J Biosci"},{"key":"R39-26-20230811","first-page":"288","article-title":"Pyroglutamic acid: Throwing light on a lightly studied metabolite.","volume":"102","author":"Kumar","year":"2012","journal-title":"Curr Sci"},{"key":"R40-26-20230811","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13813450701661198","article-title":"The central role of glutathione in the pathophysiology of human diseases.","volume":"113","author":"Franco","year":"2007","journal-title":"Arch Physiol Biochem"},{"key":"R41-26-20230811","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/BC.2009.033","article-title":"Glutathione dysregulation and the etiology and progression of human diseases.","volume":"390","author":"Ballatori","year":"2009","journal-title":"Biol Chem"},{"key":"R42-26-20230811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis.","volume":"30","author":"Forman","year":"2009","journal-title":"Mol Aspects Med"},{"key":"R43-26-20230811","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis.","volume":"30","author":"Lu","year":"2009","journal-title":"Mol Aspects Med"},{"key":"R44-26-20230811","doi-asserted-by":"crossref","first-page":"1652S","DOI":"10.1093\/jn\/136.6.1652S","article-title":"Mammalian cysteine metabolism: New insights into regulation of cysteine metabolism.","volume":"136","author":"Stipanuk","year":"2006","journal-title":"J Nutr"},{"key":"R45-26-20230811","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1073\/pnas.67.3.1248","article-title":"The \u03b3-glutamyl cycle: A possible transport system for amino acids.","volume":"67","author":"Orlowski","year":"1970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-26-20230811","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197608192950809","article-title":"Editorial: Glutathione deficiency, pyroglutamic acidemia and amino acid transport.","volume":"295","author":"Beutler","year":"1976","journal-title":"N Engl J Med"},{"key":"R50-26-20230811","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-2952(93)90506-R","article-title":"Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol).","volume":"46","author":"Ghauri","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R51-26-20230811","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning.","volume":"359","author":"Heard","year":"2008","journal-title":"N Engl J Med"},{"key":"R52-26-20230811","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-0528.1989.tb02420.x","article-title":"The excretion of 5-oxoproline in urine, as an index of glycine status, during normal pregnancy.","volume":"96","author":"Persaud","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"R53-26-20230811","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S0007114598001767","article-title":"Infants in Trinidad excrete more 5-L-oxoproline (L-pyroglutamic acid) in urine than infants in England: An environmental not ethnic difference.","volume":"80","author":"Lenton","year":"1998","journal-title":"Br J Nutr"},{"key":"R54-26-20230811","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1016\/S0021-9258(19)45858-4","article-title":"Partial reactions catalyzed by gamma-glutamylcysteine synthetase and evidence for an activated glutamate intermediate.","volume":"246","author":"Orlowski","year":"1971","journal-title":"J Biol Chem"},{"key":"R55-26-20230811","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/S0021-9258(19)40988-5","article-title":"5-Oxo-L-prolinase (L-pyroglutamate hydrolase). Purification and catalytic properties.","volume":"250","author":"Van Der Werf","year":"1975","journal-title":"J Biol Chem"},{"key":"R56-26-20230811","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0676.1988.tb00984.x","article-title":"Long-term administration of toxic doses of paracetamol (acetaminophen) to rats.","volume":"8","author":"Poulsen","year":"1988","journal-title":"Liver"},{"key":"R57-26-20230811","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.110.166421","article-title":"Oxidation of plasma cysteine\/cystine and GSH\/GSSG redox potentials by acetaminophen and sulfur amino acid insufficiency in humans.","volume":"333","author":"Mannery","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"R58-26-20230811","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1203\/01.pdr.0000196370.57200.da","article-title":"Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts.","volume":"59","author":"Mannucci","year":"2006","journal-title":"Pediatr Res"},{"key":"R59-26-20230811","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI115103","article-title":"Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading.","volume":"87","author":"Coor","year":"1991","journal-title":"J Clin Invest"},{"key":"R60-26-20230811","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.00318.2010","article-title":"The pathogenesis of cystinosis: Mechanisms beyond cystine accumulation.","volume":"299","author":"Wilmer","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R62-26-20230811","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF02631123","article-title":"Sulfation and glucuronidation of acetaminophen by cultured hepatocytes reproducing in vivo sex-differences in conjugation on Matrigel and type 1 collagen.","volume":"27A","author":"Kane","year":"1991","journal-title":"In Vitro Cell Dev Biol"},{"key":"R63-26-20230811","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinchem\/44.2.336","article-title":"Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy.","volume":"44","author":"Croal","year":"1998","journal-title":"Clin Chem"},{"key":"R64-26-20230811","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(89)90158-X","article-title":"Pyroglutamicaciduria from vigabatrin.","volume":"1","author":"Bonham","year":"1989","journal-title":"Lancet"},{"key":"R65-26-20230811","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(89)91821-7","article-title":"Vigabatrin and urinary 5-oxoproline.","volume":"2","author":"Meister","year":"1989","journal-title":"Lancet"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201401000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:48Z","timestamp":1786369428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201401000-00026"}},"subtitle":["A Tale of Two Cycles, One an ATP-Depleting Futile Cycle and the Other a Useful Cycle"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07730713","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}